Juliane Volkmann et al. (30) discovered that the CRYAB gene is unexpressed or only weakly expressed in 75% of ovarian cancer samples, whereas high CRYAB expression correlates with poor outcomes (OS, PFS) in ovarian cancer patients. This evidence concerns the gene CRYAB and ovarian carcinoma.